Genes and Environment in Multiple Sclerosis
NCT01353547 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-05-14
Summary
The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.
Conditions
Sponsors & Collaborators
-
University of Pittsburgh
collaborator OTHER -
Brigham and Women's Hospital
collaborator OTHER - lead OTHER
Principal Investigators
-
Zongqi Xia, MD, PhD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2040-10-31
- Completion
- 2040-10-31
Countries
- United States
Study Locations
More Related Trials
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Identifying and Characterizing Preclinical MS
NCT05787795 ·Status: RECRUITING
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
NCT01396343 ·Status: COMPLETED
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
NCT01804647 ·Status: COMPLETED
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Multiple Sclerosis Prediction and Monitoring of Progression Study
NCT05685784 ·Status: RECRUITING ·Phase: NA
-
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NCT06919900 ·Status: RECRUITING ·Phase: NA
-
A Systems Approach to Understanding Disease Processes in Multiple Sclerosis
NCT05081700 ·Status: COMPLETED
-
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population
NCT01804660 ·Status: COMPLETED
-
Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II
NCT03797937 ·Status: COMPLETED ·Phase: NA
-
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
NCT03111394 ·Status: COMPLETED
-
Cellular microRNA Signatures in Multiple Sclerosis
NCT05290688 ·Status: UNKNOWN ·Phase: NA
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
NCT05941975 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study
NCT05426980 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis
NCT00087529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve
NCT06410326 ·Status: COMPLETED
-
Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.
NCT02769767 ·Status: UNKNOWN
-
Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
NCT06309173 ·Status: WITHDRAWN
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2